Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.139 USD | -4.84% | -4.84% | +22.94% |
Jun. 11 | Irish banks can absorb commercial real estate price shock, regulator says | RE |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.56B 4.88B | Sales 2025 * | 4.34B 4.65B | Capitalization | 11.58B 12.4B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.89B | Net income 2025 * | 1.56B 1.67B | EV / Sales 2024 * | 2.54 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.67 x |
P/E ratio 2024 * |
6.67
x | P/E ratio 2025 * |
6.94
x | Employees | 10,551 |
Yield 2024 * |
6.28% | Yield 2025 * |
6.66% | Free-Float | 69.04% |
Latest transcript on AIB Group plc
1 day | -4.84% | ||
1 week | -4.84% | ||
Current month | -9.77% | ||
1 month | -0.60% | ||
3 months | +5.30% | ||
6 months | +27.83% | ||
Current year | +22.94% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Basil Geoghegan
BRD | Director/Board Member | - | 19-09-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 5.139 | -4.84% | 20,092 |
24-06-06 | 5.4 | +2.27% | 12,638 |
Delayed Quote OTC Markets, June 14, 2024 at 10:33 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.92% | 556B | |
+16.54% | 307B | |
+13.61% | 253B | |
+18.28% | 179B | |
+25.50% | 170B | |
+6.50% | 158B | |
+6.62% | 147B | |
-6.57% | 145B | |
+12.08% | 139B |
- Stock Market
- Equities
- A5G Stock
- AIBRF Stock